New guidelines for conducting systematic reviews of animal and cell studies

A new publication in Nature Reviews Methods Primers provides essential guidance for conducting rigorous systematic reviews on studies with animals and cells.

Takeda defends Alzheimer’s pact, TYK2 potential as restructuring is in ‘full swing’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 1, 2024

Vivoryon issues updates on its Alzheimer’s therapy programme – Pharmaceutical Technology

Vivoryon reported initiating preparations for an open-label extension study to investigate long-term outcomes for patients treated under VIVIAD or VIVA-MIND protocols. Image Credit: Puwadol Jaturawutthichai

July 17, 2023

$2.4 million grant to fund project PAL for building diversity in speech-language pathology

The Department of Audiology and Speech Pathology at the University of Tennessee Health Science Center and the Department of Hearing and Speech Sciences at Vanderbilt

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.